(Q43910711)

28 November 2017

title

Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication (English)

1 reference

28 November 2017

1 reference

Ecclissato C

1

1 reference

28 November 2017

Marchioretto MA

2

1 reference

28 November 2017

Mendonça S

3

1 reference

28 November 2017

Godoy AP

4

1 reference

28 November 2017

Guersoni RA

5

1 reference

28 November 2017

Deguer M

6

1 reference

28 November 2017

Piovesan H

7

1 reference

28 November 2017

Ferraz JG

8

1 reference

28 November 2017

Pedrazzoli J

9

1 reference

28 November 2017

publication date

1 February 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

7

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

53-59

1 reference

Regular review: treatment of Helicobacter pylori infection

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Antibiotic resistance in Helicobacter pylori: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Childhood living conditions and Helicobacter pylori seropositivity in adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Epidemiology of Helicobacter pylori in Southern China: Identification of Early Childhood as the Critical Period for Acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Helicobacter pylori infection in childhood: risk factors and effect on growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Eradication of Helicobacter pylori in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Furazolidone combination therapies for Helicobacter pylori infection in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2002.00056.X

10.1046/J.1523-5378.2002.00056.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference